Related references
Note: Only part of the references are listed.A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients
Hao Tang et al.
CLINICAL CANCER RESEARCH (2013)
Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers
Xiyong Liu et al.
CLINICAL SCIENCE (2013)
Regulation of Urokinase Expression at the Posttranscription Level by Lung Epithelial Cells
Shwetha K. Shetty et al.
BIOCHEMISTRY (2012)
Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine
Elisa Dalla Pozza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair
Vincenzo D'Angiolella et al.
CELL (2012)
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Ramaswamy Govindan et al.
CELL (2012)
Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
Snjezana Dogan et al.
CLINICAL CANCER RESEARCH (2012)
Lung cancer in never smokers - A review
Sebastien Couraud et al.
EUROPEAN JOURNAL OF CANCER (2012)
p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells
Shigeto Matsushita et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
Evaluating the Therapeutic Potential of a Non-Natural Nucleotide That Inhibits Human Ribonucleotide Reductase
Md. Faiz Ahmad et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells
Giovanna Pontarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair
Ai-Guo Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer
Xiyong Liu et al.
CANCER RESEARCH (2011)
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
Lars Petter Jordheim et al.
LANCET ONCOLOGY (2011)
Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer
Vei Mah et al.
LUNG CANCER (2011)
Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization
James Wesley Fairman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Mechanisms of dNTP supply that play an essential role in maintaining genome integrity in eukaryotic cells
Hiroyuki Niida et al.
CANCER SCIENCE (2010)
Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
Teppei Morikawa et al.
HUMAN PATHOLOGY (2010)
Survival Differences by Gender for Resected Non-small Cell Lung Cancer A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study
Hiroyuki Sakurai et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)
Jae Jin Lee et al.
LUNG CANCER (2010)
Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms
Xia Xu et al.
CANCER RESEARCH (2008)
Molecular genetics of lung cancer in people who have never smoked
Janakiraman Subramanian et al.
LANCET ONCOLOGY (2008)
Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage
Giovanna Pontarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network
Liu-Ya Tang et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Aromatase expression predicts survival in women with early-stage non-small cell lung cancer
Vei Mah et al.
CANCER RESEARCH (2007)
RRM2 induces NF-κB-dependent MMP-9 activation and enhances cellular invasiveness
Mark S. Duxbury et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Understanding ribonucleotide reductase inactivation by gemcitabine
Nuno M. F. S. A. Cerqueira et al.
CHEMISTRY-A EUROPEAN JOURNAL (2007)
DNA precursor metabolism and genomic stability
Christopher K. Mathews
FASEB JOURNAL (2006)
Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells
P Håkansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
R Rosell et al.
CLINICAL CANCER RESEARCH (2004)
An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines
JD Davidson et al.
CANCER RESEARCH (2004)
Mouse ribonucleotide reductase R2 protein: A new target for anaphase-promoting complex-Cdh1-mediated proteolysis
AL Chabes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
H Tanaka et al.
NATURE (2000)